 |
|
Nottingham biosciences million pound injection
July 30, 2007Nottingham's strength as a UK Science City is further underlined today, with news that the Wellcome Trust, the UK's largest medical research charity, has awarded almost £1 million to an innovative biosciences company.
The investment, under the Translation Award programme, will help Nottingham-based RegenTec Ltd to develop commercial products in the rapidly-developing field of regenerative medicine. The company has perfected techniques which could greatly enhance the repair of bone defects and fractures.
RegenTec Ltd was created to build on the world-changing research carried out by scientists at The University of Nottingham, Britain's 'University of the Year'. With support from the East Midlands Development Agency, the company has invented a unique material that works with stem cells and biopharmaceuticals to stimulate the regeneration of tissue in patients.
When injected into the body the material forms a highly porous scaffold structure, which encourages new tissues to form.
The unique scaffold mechanism also assists the delivery of stem cells and drugs without compromising their effectiveness. This offers a substantial opportunity to deliver a cure to patients with bone, liver, heart or nerve tissue defects.
Professor Kevin Shakesheff, Chief Scientific Officer at RegenTec, and Director of The Centre for Biomolecular Sciences at The University of Nottingham, said: "The ability to inject these scaffold materials could significantly reduce the need for invasive surgery in tissue repair.
"It will mean that operation and rehabilitation times could come down significantly. After injection, the porous material we use gradually degrades, leaving behind only newly formed bone tissue."
RegenTec has developed an extensive portfolio of patents and hopes that its injectable technology can reach clinics within three years. Its first product - Injectabone - will be used as a replacement for bone grafting, which can be beset by problems which include a short supply of host bone, chronic post-operative pain, and an increased risk of infection. Injectabone will be launched in the US and European markets for use by orthopaedic surgeons.
The material will then be adapted to help in treatment of many other diseases.
Dr Robin Quirk, Managing Director, said: "Regenerative medicine is a hugely exciting worldwide industry that promises to radically improve many aspects of clinical practice. We have a world-first technology that has a remarkable range of future uses.
"The Wellcome Trust Award is a substantial step forward in ensuring that the UK plays a major role in the commercial and clinical development of regenerative medicine."
Dr Susan Huxtable, Director of Intellectual Property and Commercialisation at The University of Nottingham, said: "The Wellcome Trust Award is recognition of the hard work and creativity of a large team of scientists who have worked at the University of Nottingham and within Regentec over the past five years.
"They are pioneers in terms of their science, but also in ensuring that the expertise and knowledge honed in a research-intensive university can be translated into commercial enterprise, and make a dynamic contribution to well-being and economic growth. We have enjoyed a record year in attracting third party investment to our portfolio of spin-out companies."
The University of Nottingham
When injected into the body the material forms a highly porous scaffold structure, which encourages new tissues to form.
The unique scaffold mechanism also assists the delivery of stem cells and drugs without compromising their effectiveness. This offers a substantial opportunity to deliver a cure to patients with bone, liver, heart or nerve tissue defects.
Professor Kevin Shakesheff, Chief Scientific Officer at RegenTec, and Director of The Centre for Biomolecular Sciences at The University of Nottingham, said: "The ability to inject these scaffold materials could significantly reduce the need for invasive surgery in tissue repair.
"It will mean that operation and rehabilitation times could come down significantly. After injection, the porous material we use gradually degrades, leaving behind only newly formed bone tissue."
RegenTec has developed an extensive portfolio of patents and hopes that its injectable technology can reach clinics within three years. Its first product - Injectabone - will be used as a replacement for bone grafting, which can be beset by problems which include a short supply of host bone, chronic post-operative pain, and an increased risk of infection. Injectabone will be launched in the US and European markets for use by orthopaedic surgeons.
The material will then be adapted to help in treatment of many other diseases.
Dr Robin Quirk, Managing Director, said: "Regenerative medicine is a hugely exciting worldwide industry that promises to radically improve many aspects of clinical practice. We have a world-first technology that has a remarkable range of future uses.
"The Wellcome Trust Award is a substantial step forward in ensuring that the UK plays a major role in the commercial and clinical development of regenerative medicine."
Dr Susan Huxtable, Director of Intellectual Property and Commercialisation at The University of Nottingham, said: "The Wellcome Trust Award is recognition of the hard work and creativity of a large team of scientists who have worked at the University of Nottingham and within Regentec over the past five years.
"They are pioneers in terms of their science, but also in ensuring that the expertise and knowledge honed in a research-intensive university can be translated into commercial enterprise, and make a dynamic contribution to well-being and economic growth. We have enjoyed a record year in attracting third party investment to our portfolio of spin-out companies."
The University of Nottingham
Stem Cells Current Events and Stem Cells News RSSPure insulin-producing cells produced in mouse
Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).
Adult stem cell breakthrough
The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.
First trachea transplant without immunosuppression
After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis.
First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure.
New imaging technique tracks cancer-killing cells over prolonged period
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders.
Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age
A new study confirms that exercise can reverse the age-related decline in the production of neural stem cells in the hippocampus of the mouse brain, and suggests that this happens because exercise restores a brain chemical which promotes the production and maturation of new stem cells.
Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord
Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord.
Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find
Researchers at UT Southwestern Medical Center have uncovered new insights into the "Dr. Jekyll and Mr. Hyde" nature of a protein that stimulates stem-cell maturation in the brain but, paradoxically, can also lead to nerve-cell damage.
The bonsai effect: Wounded plants make jasmonates, inhibiting cell division, stunting growth
It is well known that plants growing under unfavourable conditions are generally smaller than those growing in stress-free conditions: indeed it is estimated that in the US, abiotic stress reduces the yield of agricultural crops by an average of 22%.
Stem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells
Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in the October issue of the journal Stem Cells, suggest dental pulp stem cells show promise for use in cell therapy and regenerative medicine, particularly therapies associated with the central nervous system.
More Stem Cells Current Events and Stem Cells News Articles
 | The Stem Cell Divide: The Facts, the Fiction, and the Fear Driving the Greatest Scientific, Political, and Religious Debate of Our Time by Michael Bellomo As politics, religion, and the media weigh in on the complex stem cell issue, more and more of the scientific reality is getting lost. In the search for the truth, "The Stem Cell Divide" does not take sides and debunks the distortions and exaggerations that come from every camp, while providing a complete picture of what scientists have accomplished so far, what they're currently doing and what... |
 | Stem Cell Now by Christopher Thomas Scott The essential account of the most important scientific advance—and most volatile ethical debate—of our time While many believe stem cell research holds the key to curing a wide range of ailments, others see this research as opening a Pandora’s box that will devalue human life. In Stem Cell Now, Christopher Scott—executive director of Stanford University’s Stem Cells and Society... |
 | Stem Cell Research: Medical Applications And Ethical Controversy (The New Biology) by Joseph, Ph.D. Panno This is an informative reference to the technological advances, applications, and issues of stem cell research. The past few years have seen controversy and debate surrounding stem cell research. Because skin cells have the capability to divide - unlike most of the cells in our body - our skin can heal itself through the division of cells. Scientists have attempted to apply this concept to major... |
 | The Stem Cell Controversy: Debating the Issues (Contemporary Issue Series) Stem cell research is headline news. Researchers are eager to move forward, state governments and private foundations are rushing to support it, and the sick and afflicted are desperate for its benefits. Yet powerful forces in our society - led by President George W. Bush - find it morally troubling and they are doing all in their powers to restrict its development beyond a very limited scale.... |
 | Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical, and Political Issues Few recent advances in science have generated as much excitement and controversy as human embryonic stem cells. The potential of these cells to replace diseased or damaged cells in virtually every tissue of the body heralds the advent of an extraordinary new field of medicine. Controversy arises, however, because current techniques required to harvest stem cells involve the destruction of the... |
 | Essentials of Stem Cell Biology by Robert Lanza, E. Donnall Thomas, James Thomson, Roger Pedersen, John Gearhart, Brigid Hogan, Douglas Melton, Michael West This abridged version of the bestselling reference Handbook of Stem Cells, Two-Volume Set attempts to incorporate all the essential subject matter of the original two-volume edition in a single volume. The material has been reworked in an accessible format suitable for students and general readers interested in following the latest advances in stem cells, including full color presentation... |
 | Stem Cell Century: Law and Policy for a Breakthrough Technology by Russell Korobkin The explosion of interest in stem cell research raises a raft of controversial policy questions. When should human embryos be used to create stem cells? Should cloning be outlawed? Should egg and tissue donors be paid? Should we allow scientists to patent stem cells? Is the government entitled to a portion of the revenue from stem cell technology created with public funds? How should the... |
 | The Stem Cell Dilemma: Beacons of Hope or Harbingers of Doom? by Leo Furcht, William Hoffman TodayÕs scientists are showing us how stem cells create and repair the human body. Unlocking these secrets has become the new Holy Grail of biomedical research. But behind that search lies a sharp divide. Stem cells offer the hope of creating or repairing tissues lost to age, disease, and injury. Yet because of this ability, stem cells hold the potential to incite an international biological... |
 | Cell of Cells: The Global Race to Capture and Control the Stem Cell by Cynthia Fox Positioned at the cutting edge of science, Cell of Cells charts the international race to utilize the stem cell.From a lab in the Sahara, where one problem is sand in the petri dishes, to an Israeli lab that narrowly escapes a terrorist bomb, stem cells have gone global. Not only are the cells studied in an escalating number of labs—and lands—but they are already being used. In Japan, a... |
 | Stem Cell Wars: Inside Stories from the Frontlines by Eve Herold Americans have become the victims of misinformation about stem cell research. Over the last few years, the stem cell debate has been intensely political, religious, and confusing to many people. Now, Eve Herold explains what this science is all about, who is for and against it, and why it must go forward. She pulls together fascinating stories to highlight every aspect of this multifaceted... |
| © 2008 BrightSurf.com |